ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2032

Results From a Multicentre International Registry of Familial Mediterranean Fever: Impact of Genetic and Environment Factors On the Expression of a Monogenic Disease in Children

Seza Ozen1, Erkan Demirkaya2, Gayane Amaryan3, Isabelle Koné-Paut3, Adem Polat3, Turker Turker3, Patricia Woo4, Yosef Uziel5, Consuelo Modesto3, Martina Finetti3, Pierre Quartier6, Efimia Papadopoulou-Alataki3, Sulaiman Al-Mayouf3, Giovanna Fabio3, Romina Gallizzi7, Luca Cantarini8, Joost Frenkel9, Susan Nielsen10, Michael Hofer3, Antonella Insalaco3, Huri Ozdogan3, Nicolino Ruperto3 and Marco Gattorno3, 1Hacettepe University, Ankara, Turkey, 2Gulhane Military Medical Faculty, Ankara, Turkey, 3Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, 4University College London, London, United Kingdom, 5Pediatric Rheumatology, Meir medical center, Kfar Saba, Israel, 6Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, 7University of Messina, Messina, Italy, 8University of Siena, Siena, Italy, 9University Medical Center Utrecht, Utrecht, Netherlands, 10Istituto Giannina Gaslini, Genoa, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Environmental factors and familial Mediterranean fever

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Familial Mediterranean Fever (FMF) is an autoinflammatory disease caused by mutations in a single gene, the MEFV gene. The disease is very frequent among patients with an eastern European ancestry but may occur in much lesser frequencies in other ethnic groups as well. We present the disease characteristics in patients living in the eastern Mediterranean and how they compare to the eastern Mediterranean patients living in western Europe and to the Europeans.

Methods:

The data was extracted from the Eurofever project, that accomplished a multicenter registry for the autoinflammatory diseases in Europe and neighboring countries. From this registry 346 FMF patients whose diagnosis was confirmed were the subjects of this study. We developed a disease severity score that was modified from and harmonized the existing scores in the literature.

Results:

The disease manifestations such as fever, abdominal pain, acute phase reactants were similar in all patients. The genetics and demographic features with increased acute phase reactants were similar among eastern Mediterranean patients whether they lived in their countries or western European countries. The mutation distribution of the European patients displayed differences and they were diagnosed later. On the other hand when features suggesting a severe disease expression were analysed, the eastern Mediterranean patients living in Europe were significantly different than those living in their countries and were similar to European patients and displayed milder phenotypic manifestations, with less attacks, less arthritis and less chest pain. When multivariate analysis was applied to assess the effect of residence, not ethnicity but the  country of residence positively influenced the severity of disease presentation. Other independent variables were the presence of M694V (also on a.  single allele), a positive family history  together with disease delay.  

Conclusion: We clearly demonstrate the actual impact of environment and genetic factors on the expression of a monogenic disease. We suggest that since FMF is the disease of the innate immune system and since the mutated protein is a component of the inflammasome triggered by microbial products, environmental factors including diet have a significant effect. Epigenetic studies are now in order.


Disclosure:

S. Ozen,
None;

E. Demirkaya,
None;

G. Amaryan,
None;

I. Koné-Paut,
None;

A. Polat,
None;

T. Turker,
None;

P. Woo,
None;

Y. Uziel,
None;

C. Modesto,
None;

M. Finetti,
None;

P. Quartier,
None;

E. Papadopoulou-Alataki,
None;

S. Al-Mayouf,
None;

G. Fabio,
None;

R. Gallizzi,
None;

L. Cantarini,
None;

J. Frenkel,
None;

S. Nielsen,
None;

M. Hofer,
None;

A. Insalaco,
None;

H. Ozdogan,
None;

N. Ruperto,
None;

M. Gattorno,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/results-from-a-multicentre-international-registry-of-familial-mediterranean-fever-impact-of-genetic-and-environment-factors-on-the-expression-of-a-monogenic-disease-in-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology